Georgia McCaughan, Haematologist at St Vincent’s Hospital, shared a post on X:
“Phoebe Joy Ho presents at LBA ASH25 first 4 RRMM patients treated with KLN-1010, a modified lentiviral vector generating anti-BCMA CAR-T in vivo CAR-T expansion without LD All patients achieved early MRD neg No significant early safety concerns Looking forward to more data!”
More updates from ASH25 on OncoDaily.
